- United States
- Mo.
- Letter
The recent cancellation of federal office leases, including the potential closure of the massive FDA facility in St. Louis, raises serious concerns about public health and safety. This FDA building plays a crucial role in drug testing and research, ensuring the medications we rely on are thoroughly vetted for safety and efficacy. Shuttering such a vital facility jeopardizes the rigorous evaluation processes that protect us from dangerous or ineffective pharmaceuticals. The public deserves robust oversight and scrutiny of the drugs they consume, and this facility is integral to that mission. I urge you to reconsider these lease cancellations, particularly for essential operations like the FDA, which safeguard our well-being through their diligent work. Maintaining fully functioning research and testing capabilities is paramount to a healthy society.